Suscribirse

Risk of Malignancy and Need for Surgery in Pediatric Patients with Morris or Y-chromosome Turner Syndrome: A Multicenter Survey - 05/07/15

Doi : 10.1016/j.jpag.2014.09.015 
Ciro Esposito, PhD 1, , Maria Escolino, MD 1, Vincenzo Bagnara, MD 2, Felicitas Eckoldt-Wolke, MD 3, Maciej Baglaj, MD 4, Amulya Saxena, PhD 5, Dariusz Patkowski, PhD 4, Felix Schier, PhD 3, Alessandro Settimi, PhD 1, Helene Martelli, PhD 6, Antonio Savanelli, MD 1
1 Department of Translational Medical Sciences, University of Naples “Federico II”, Naples, Italy 
2 Department of Pediatric Surgery, Catania University, Catania, Italy 
3 Department of Pediatric Surgery, Medical University of Jena, Jena, Germany 
4 Department of Pediatric Surgery, Wrocław Medical University, Wrocław, Poland 
5 Department of Pediatric Surgery, Chelsea and Westminster Children Hospital, London, UK 
6 Department of Pediatric Surgery, Hôpital de Bicetre, Paris, France 

Address correspondence to: Prof. Ciro Esposito, PhD, Department of Traslational Medical Sciences, “Federico II” University of Naples, Via Pansini 5, 80131 Naples, Italy; Phone: +39 081 746 33 77; fax: +39 081 746 33 61
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Sunday 05 July 2015

Abstract

Study Objective

The management of intersex patients with Y-chromosome Turner or Morris syndrome remains a challenge. We report our experience with a multicenter European survey.

Design

We collected the data on 18 patients (mean age 10.2 years, range 2-17 years) with Morris (10 patients) or Turner (8 patients) syndrome harboring the Y chromosome who were treated in 1 of 6 European centers of pediatric surgery between 1997 and 2013. All patients were evaluated by use of a multidisciplinary diagnostic protocol. All patients received a bilateral gonadectomy via laparoscopy; only 1 center performed ovarian cryopreservation. Seven patients received a concomitant genitoplasty. Operative notes and histology were reviewed for details.

Results

No conversions to laparotomy and no complications were recorded. For the patients receiving only the gonadectomy, the length of hospital stay was 24-48 hours, whereas for the patients receiving an associated genitoplasty, it was 6-10 days. Specimens were negative for tumors in 83.3% of cases, whereas in 3 patients (16.6%), benign abnormalities (Sertoli cell hyperplasia in 1 patient and ovotestis in 2 patients) were recorded. A malignant tumor was not recorded in our series.

Conclusion

If the risk of malignancy is considered as the main indication for surgery in case of Turner or Morris syndrome, on the basis of our study, this indication should be reevaluated. However, based on the non-negligible rate of benign abnormalities reported in our series (16.6%), the performance of cryopreservation to preserve fertility and the possibility of performing genitoplasty during the same anesthetic procedure represent additional valid indications for surgery.

El texto completo de este artículo está disponible en PDF.

Key Words : Laparoscopic gonadectomy, Intersex disorders, Tumor, Genitoplasty, Ovarian cryopreservation


Esquema


 The authors indicate no conflicts of interest.


© 2015  North American Society for Pediatric and Adolescent Gynecology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.